Related Experiment Video
Updated: Dec 29, 2025

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression
Published on: April 18, 2025
Pseudomonas aeruginosa Alginate Benefits Staphylococcus aureus?
1University of Colorado Anschutz Medical Campus, Department of Immunology and Microbiology, Aurora, Colorado, USA michael.schurr@cuanschutz.edu.
Pseudomonas aeruginosa exopolysaccharide alginate protects Staphylococcus aureus by reducing P. aeruginosa virulence factors. This finding explains coinfections in cystic fibrosis patients.
Area of Science:
- Microbiology
- Bacterial interactions
- Infectious diseases
Background:
- Pseudomonas aeruginosa and Staphylococcus aureus are opportunistic pathogens.
- Coinfections with P. aeruginosa and S. aureus are common in cystic fibrosis.
- P. aeruginosa typically inhibits S. aureus growth through virulence factors.
Purpose of the Study:
- To investigate the role of P. aeruginosa-produced alginate in mediating S. aureus survival during coinfection.
- To determine if alginate affects P. aeruginosa virulence factor expression.
Main Methods:
- Assessing the impact of exogenously added alginate on P. aeruginosa virulence gene expression.
- Evaluating the effect of alginate on S. aureus respiration and cell membrane integrity in co-culture.
Main Results:
- Alginate dampens the expression of P. aeruginosa virulence products.
- This reduction in virulence factors allows S. aureus to maintain respiration and cell membrane integrity.
- Exogenously added alginate influences P. aeruginosa competitive interactions.
Conclusions:
- P. aeruginosa alginate provides a protective effect for S. aureus during coinfection.
- This mechanism offers a partial explanation for S. aureus and P. aeruginosa coinfections in cystic fibrosis.
- Alginate represents a potential target for therapeutic interventions in polymicrobial infections.
More Related Videos
09:06Culture of Small Colony Variant of Pseudomonas aeruginosa and Quantitation of its Alginate
Published on: February 22, 2020
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021